| http://www.w3.org/ns/prov#value | - Using its novel particle formulation, the company has developed NanoGENT, an inhaled dry-powder formulation of gentamicin, to provide early treatment for exposure to biological warfare agents, as well as TB and other respiratory infections.
|
